Company: CDLX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001666071-25-000034
Chunk: 126

Company: Cardlytics, Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 8
Chunk 126
---
 financing costs charged to interest expense1,633 1,648 1,595 Amortization of right-of-use asset2,187 3,055 6,196 Impairment of goodwill and intangible assets131,595 70,518 453,288 Loss on divestiture— 6,550 — Gain on debt extinguishment(13,017)— — Stock-based compensation expense40,367 40,980 44,686 Change in contingent consideration210 1,246 (128,174)Other non-cash expense (income), net1,481 (4,170)6,589 Income tax benefit— — (1,446)Change in operating assets and liabilities:Accounts receivable and contracts assets, net12,497 (7,725)(4,546)Prepaid expenses and other assets1,360 2,492 535 Accounts payable499 239 (893)Other accrued expenses(6,644)(7,492)(9,516)Partner Share liability(16,350)405 1,721 Customer Incentive liability(7,133)(1,393)1,382 Net cash used in operating activities(8,824)(185)(53,904)Investing activitiesAcquisition of property and equipment(1,562)(667)(1,171)Acquisition of patents— — (175)Capitalized software development costs(17,736)(11,725)(12,140)Business acquisitions, net of cash acquired— — (2,274)Proceeds from divestitures, net of cash divested552 2,330 — Net cash used in investing activities(18,746)(10,062)(15,760)Financing activitiesProceeds from issuance of debt172,500 30,000 — Principal payments of debt(199,303)(31)(35)Proceeds from termination of capped calls related to convertible notes115 — — Proceeds from issuance of common stock48,645 55 379 Settlement of contingent consideration(14,167)(50,050)— Repurchase of common stock— — (40,000)Equity issuance costs(309)— (157)Debt issuance costs(6,037)— (174)Net cash provided by (used in) financing activities1,444 (20,026)(39,987)